Norway’s King Harald Hospitalized in Oslo
Moderna shares surge on melanoma vaccine breakthrough
Moderna shares soared by as much as 150% on Wednesday after the company and Merck announced positive late-stage trial results for a personalized mRNA melanoma vaccine, marking a major breakthrough in skin cancer treatment.
Continue reading







